DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TCIRG1; IGKV6D-21; IGKV1D-8; IGLV3-12; IGKV1D-33; IGKV2D-24; TRAV2; IGKV3OR2-268; IGLV3-21; IGKV3-11; IGLV7-46; IGLV5-45; IGKV2-28; IGLV4-60; IGLV3-19; IGLV9-49; IGKV2D-28; IGLV2-14; IGKV6-21; IGKV1-33; IGKV1-39; IGLV5-37; IGKV1D-39; TRDV2; IGKV2D-40; IGKV3-7; IGKV1-9; IGKV2D-29; IGLV4-3; IGKV1D-13; IGLV4-69; IGLV2-23; IGKV1D-16; IGKV2D-30; IGKV3-20; IGKV2-24; IGLV2-8; IGKV1-8; IGKV4-1; IGKV1-16; IGKV1D-17; TRAV14DV4; IGLV3-16; IGLV6-57; IGLV2-11; IGKV3D-11; TRDV1; IGKV1-27; IGKV1-6; IGKV1-12; IGKV3D-15; IGKV5-2; IGKV1-17; IGLV1-40; TRAV38-2DV8; IGKV1D-12; IGLV3-1; IGLV1-44; IGKV3D-20; TRAV18; IGKV1-5; IGLV3-25; IGKV1-13; IGLV8-61; IGLV2-18; IGLV1-36; IGLV7-43; IGLV3-27; TRAV40; IGLV1-51; IGKV2-30; TRAV38-1; IGKV2-29; TRDV3; TRAV9-2; TRAV19; IGLV1-47; IGKV3-15; IGLV3-10; IGKV1D-43; IGLV5-48; IGLV10-54;	GO:0002377~immunoglobulin production	82	107	76.6355140186916	0	0	0	0	0	0	0
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGLC6; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; IGHV1-45; TRBC2; IGHA2; IGHV1-3; IGHV3-35; IGHV1-18; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHE; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	54	99	54.5454545454545	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; FCN1; C1R; CFD; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C1S; IGLC6; IGLC2; IGLC3; IGHV1-2; MASP1; IGLV3-21; FCN2;	GO:0006956~complement activation	66	92	71.7391304347826	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C1R; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C1S; IGLC6; IGLC2; IGLC3; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHV3-35; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHE; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	94	161	58.3850931677019	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C1R; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C1S; IGLC6; IGLC2; IGLC3; CD19; IGHV1-2; IGLV3-21; CR1L;	GO:0030449~regulation of complement activation	65	113	57.5221238938053	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHE; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; JUN; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC6; IGLC2; IGLC3; IGHV1-2; PSMB8; PSMB9; FCER1G; PSMB10; PSMB3; VAV2; MAPK10; LILRA4; IGLV3-21; MS4A2; PSME1; PSMA8; PSMF1; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	73	171	42.6900584795322	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; ARPC1B; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC6; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; VAV2; NCKAP1L; ACTB; IGLV3-21; PRKCD;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	68	135	50.3703703703704	0	0	0	0	0	0	0
up	IRGM; LYZL6; HP; PPBP; ELANE; CEBPB; TNFRSF1A; BCL3; IL10; CAMP; CXCL6; S100A12; IRF8; PRKCD; CEBPE; DEFB108B; TLR9; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGLC6; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; IGHE; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-35; IGHV3-23; FCER1G; IGHV1-69; HAMP; IGHV1-69-2; IGHV4-31; IGLC7; TRDC; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; GSDMD; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	77	216	35.6481481481481	0	0	0	0	0	0	0
up	MS4A1; CD19; CTLA4; PTPN6; MNDA; NCKAP1L; LAT2; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-35; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHV1-46; IGLC6; IGHV4-59; IGHV3-64; IGHV6-1; IGHV1-45; IGHG3; IGHV1-18; IGHV1-24; IGLC7; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHE; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	62	125	49.6	0	0	0	0	0	0	0
up	TNIP2; TLR9; IGHV1-45; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGHE; IGLC2; IGHV3-20; IGHV1-46; IGLC6; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-35; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	56	98	57.1428571428571	0	0	0	0	0	0	0
up	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; TNFRSF10B; SDC3; JCHAIN; IGKV1D-33; IGKV1-33; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; GYPA; IGLV7-43; CD74; IGKV1-16; IGKV1D-39; IGKV3-11; ITGB1; GYPB; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; DBH; CD48; IGLC6; IGLC2; IGLC3; ATP1B2; SELP; IGHV1-2; PTPN6; FCER1G; CEACAM8; SDC2; CEACAM3; IGLV3-21; ANGPT1; SIRPG; CD84;	GO:0050900~leukocyte migration	78	193	40.4145077720207	0	0	0	0	0	0	0
down	EVPLL; FOXN1; KRT34; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KLK7; BNC1; KRT32; KRT31; ACER1; SPRR2F; SPRR2G; CALML5; SPRR3; KLK5;	GO:0008544~epidermis development	22	82	26.8292682926829	0	0	0	0	0	0	0
down	ADGRV1; GABRQ; GABRB2; HTR3B; CHRNB4; GABRA3; GABRR1; GABRA4;	GO:0050877~nervous system process	8	52	15.3846153846154	0.00012397466274605	0.00889518205202919	0.350972270234072	0.355807282081168	0.308696910237668	0.350972270234072	0.0759600262377471
down	UPK1A; UPK1B; COL4A1; GSTA1; KRT3; BMP7; KRT4; DLX5; CNN3;	GO:0030855~epithelial cell differentiation	9	68	13.2352941176471	0.0001342980301302	0.00940086210911462	0.380063425268491	0.385435346473699	0.325001232915105	0.380063425268491	0.0802782594317886
down	WNT9A; GJB3; TNC; AQP1; WNT5A; WNT3; WNT7B; FZD10; BRINP1;	GO:0071300~cellular response to retinoic acid	9	69	13.0434782608696	0.00014846359448539	0.00978718451963798	0.419855045204691	0.426090516173078	0.346514029528907	0.419855045204691	0.0835772431139596
down	GFRA3; NFASC; EDNRB; UGT8; NTF3; NTF4;	GO:0007422~peripheral nervous system development	6	27	22.2222222222222	0.00015305089196515	0.00978718451963798	0.432674871585497	0.439256059939999	0.353221248393164	0.432674871585497	0.0835772431139596
down	GLI3; BMP7; ITGA8; IRX3; SOX17; ROBO2;	GO:0001656~metanephros development	6	29	20.6896551724138	0.00021491158487396	0.0131233244380486	0.607125227268956	0.616796248588285	0.425954761220202	0.606910315684082	0.112066067092268
down	CYP1A1; AQP1; MT2A; MT1A; MT1M; MT1H;	GO:0071280~cellular response to copper ion	6	29	20.6896551724138	0.00021491158487396	0.0131233244380486	0.607125227268956	0.616796248588285	0.425954761220202	0.606910315684082	0.112066067092268
down	RDH16; CYP1A1; CYP2C9; CYP3A5; UGT1A1; CYP2C19; UGT1A8;	GO:0008202~steroid metabolic process	7	44	15.9090909090909	0.00027250651625476	0.0159610959520649	0.769285895387207	0.782093701651181	0.480974001189663	0.769013388870952	0.136299095421602
down	AKR1B15; AKR1B10; RDH16; CYP1A1; CYP3A5; ADH1C; ADH1B;	GO:0042572~retinol metabolic process	7	44	15.9090909090909	0.00027250651625476	0.0159610959520649	0.769285895387207	0.782093701651181	0.480974001189663	0.769013388870952	0.136299095421602
down	S100A8; EDN3; EDN2; CXCL9; CCL17; CXCL10; CCL11; CCL19; CXCL11;	GO:0030593~neutrophil chemotaxis	9	76	11.8421052631579	0.00028675197614636	0.0164595634308011	0.808927324708881	0.822978171540053	0.493786902924032	0.808927324708881	0.140555737111676
down	FGF1; ADRA2B; ADRA2C; NTF3; WNT5A; DYNAP;	GO:0032148~activation of protein kinase B activity	6	32	18.75	0.00034284654571414	0.0192935212980315	0.966827258913898	0.983969586199606	0.528669373491217	0.966827258913898	0.164756198967584
down	BCHE; TH; PTN; SLC6A1; ARC; STRA6; PAK6; PAK5;	GO:0007612~learning	8	62	12.9032258064516	0.00036688600002343	0.0202140635133218	1	1	0.541156850034569	0.999985158733297	0.172617129797038
down	DKK1; SOSTDC1; SFRP1; TSKU; MDFI; DKK4; NKD2;	GO:0030178~negative regulation of Wnt signaling pathway	7	47	14.8936170212766	0.00039054969501872	0.0207569930500694	1	1	0.553408917841536	0.999985158733297	0.177253453327616
down	S100A8; FGF1; GLI3; SDC1; TNC; WNT5A; CCM2L; SPRR3; EVPLL;	GO:0042060~wound healing	9	82	10.9756097560976	0.0004776255615857	0.0241209012345177	1	1	0.59368857305103	0.999985158733297	0.205979403224704
down	KRT18; KRT16; KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	5	22	22.7272727272727	0.00050333100640875	0.0241209012345177	1	1	0.60401459818758	0.999985158733297	0.205979403224704
down	EDN3; EDN2; EDNRB;	GO:0014826~vein smooth muscle contraction	3	4	75	0.0005115206265327	0.0241209012345177	1	1	0.607434497661081	0.999985158733297	0.205979403224704
down	S100A8; NOS1; NOS2;	GO:0018119~peptidyl-cysteine S-nitrosylation	3	4	75	0.0005115206265327	0.0241209012345177	1	1	0.607434497661081	0.999985158733297	0.205979403224704
down	ADCYAP1; GABRR1; GABRB2; FGF14; GABRA3; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	6	35	17.1428571428571	0.00052381204358686	0.0241209012345177	1	1	0.612362384304001	0.999985158733297	0.205979403224704
down	MMP7; MMP10; CMA1; MMP12; KLK7; TPSAB1; WDR72; KLK5;	GO:0022617~extracellular matrix disassembly	8	66	12.1212121212121	0.00053638734367322	0.0241209012345177	1	1	0.617528717074804	0.999985158733297	0.205979403224704
down	FOXP2; ELN; HOXD9; MEOX2; CAV1; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	7	50	14	0.0005462921882382	0.0241209012345177	1	1	0.621680510215079	0.999985158733297	0.205979403224704
down	EGFL8; TFAP2B; ROR1; HNF4A; HNF4G; TFAP2C; TFAP2A;	GO:0048856~anatomical structure development	7	50	14	0.0005462921882382	0.0241209012345177	1	1	0.621680510215079	0.999985158733297	0.205979403224704
down	EDN3; EDN2; HRH1; GPR62;	GO:0048016~inositol phosphate-mediated signaling	4	12	33.3333333333333	0.0005643095025607	0.0245389132174123	1	1	0.628974543425583	0.999985158733297	0.209548998653178
down	FOXP2; SOX15; DKK1; SPDEF; KLF8; IL33; TFAP2A; GLI3; AR; SCGB1A1; BMP2; HOXD8; EFNA1; CCND1; EDNRB; HOXD9; HOXA7; HOXC8; HNF1B; MMP12; CAV1; FOXF1; SIM2; CRYM; HES5; DAB2IP; BCL6B; PPP1R13L; TFAP2B; TFAP2C; AJUBA; MDFI; IRX2; PEG3; MYOZ1; TFCP2L1; HES2; NR0B2; ID4;	GO:0000122~negative regulation of transcription by RNA polymerase II	39	847	4.60448642266824	0.0006203814049438	0.0265745467490853	1	1	0.651882553493202	0.999985158733297	0.226932204030188
down	WNT9A; SDC1; WNT5A; WNT3; WNT7B; SFRP1; PORCN; FZD10;	GO:0060070~canonical Wnt signaling pathway	8	70	11.4285714285714	0.00076426195138523	0.0315754805667057	1	1	0.71033949544733	0.999985158733297	0.269637464223601
down	TF; WNT5A; WNT7B; DAB2IP; ERN2; CCL19;	GO:0007257~activation of JUN kinase activity	6	38	15.7894736842105	0.00077148921774661	0.0315754805667057	1	1	0.713098868750163	0.999985158733297	0.269637464223601
down	NFASC; MAL; UGT8;	GO:0002175~protein localization to paranode region of axon	3	5	60	0.00080313940117404	0.0315754805667057	1	1	0.725272197018707	0.999985158733297	0.269637464223601
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00080313940117404	0.0315754805667057	1	1	0.725272197018707	0.999985158733297	0.269637464223601
down	GJB1; GJA1; GJB2;	GO:1905867~epididymis development	3	5	60	0.00080313940117404	0.0315754805667057	1	1	0.725272197018707	0.999985158733297	0.269637464223601
down	IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	5	25	20	0.00083484766769503	0.0319468374171301	1	1	0.734742962197893	0.999985158733297	0.272808650146139
down	CYP1A1; CYP2C9; UGT1A1; CYP2C19; UGT1A7;	GO:0017144~drug metabolic process	5	25	20	0.00083484766769503	0.0319468374171301	1	1	0.734742962197893	0.999985158733297	0.272808650146139
down	UGT1A9; TNFRSF21; CYP1A1; HNF4A; HMGCS2; ACER1; C1QTNF2; ANGPTL4; PSAPL1;	GO:0019216~regulation of lipid metabolic process	9	92	9.78260869565217	0.0010192475146269	0.0384900048286736	1	1	0.7654548834848	0.999985158733297	0.328683748075746
down	SEMA3F; NRTN; NTF4; NTF3;	GO:0021675~nerve development	4	15	26.6666666666667	0.00113181945354579	0.0421859978139795	1	1	0.783859464980048	0.999985158733297	0.360245521909742
down	FOXP2; CYP1A1; EFEMP1; SHROOM2; HES5; STRA6;	GO:0043010~camera-type eye development	6	42	14.2857142857143	0.00123191123370692	0.0447542435536564	1	1	0.800138627950453	0.999985158733297	0.382176946430315
down	MT2A; MT1A; MT1H; MT1M;	GO:0010273~detoxification of copper ion	4	16	25	0.00138681566844401	0.0485385483955403	1	1	0.825155322724185	0.999985158733297	0.414492855582007
down	EDN3; EDN2; EDNRB; CAV1;	GO:0042310~vasoconstriction	4	16	25	0.00138681566844401	0.0485385483955403	1	1	0.825155322724185	0.999985158733297	0.414492855582007
down	GLI3; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.00138681566844401	0.0485385483955403	1	1	0.825155322724185	0.999985158733297	0.414492855582007
down	NKX2-8; AR; KRT4; PTN; WNT5A; DAB2IP; SFRP1;	GO:0050680~negative regulation of epithelial cell proliferation	7	60	11.6666666666667	0.00144731364321582	0.0500456645304747	1	1	0.8335910990456	0.999985158733297	0.427362809280913
down	CXCL11; CXCL10; APLNR; BDKRB1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	5	29	17.2413793103448	0.00150052969603265	0.0506041207990644	1	1	0.840470426997671	0.999985158733297	0.432131722673195
down	CHP2; CXCL10; FGF1; AR; EDN3; EPCAM; ADCYAP1; NTF3; EDN2; PTN; EDNRB; TNC; SERPINB3; LIFR; ID4; EFNB2; BNC1; HES5; IL34; DYNAP; SFRP1; MAPK15; TFAP2B; HOXC10; HILPDA;	GO:0008284~positive regulation of cell population proliferation	25	490	5.10204081632653	0.00152212735543134	0.0506041207990644	1	1	0.843359744737541	0.999985158733297	0.432131722673195
down	S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	IDO1; NOS1; ADCYAP1R1;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	S100A8; SERPINB3; HILPDA;	GO:0035425~autocrine signaling	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	AR; TNC; ID4;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	BCAR3; EDNRB; BCAR1;	GO:0086100~endothelin receptor signaling pathway	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	PLA2G10; MIF; PLA2R1;	GO:0090238~positive regulation of arachidonic acid secretion	3	7	42.8571428571429	0.00165741719690315	0.0506041207990644	1	1	0.859083768947754	0.999985158733297	0.432131722673195
down	DEFB4A; S100A7; PGLYRP4; PGLYRP3; CXCL9; CXCL10; CXCL11;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	7	62	11.2903225806452	0.0017197104481862	0.0519533577504672	1	1	0.864933451718897	0.999985158733297	0.443653473844787
down	S100A8; TH; NQO1; ADCYAP1; NPPC; CCND1; TNC; ADCYAP1R1; CLDN18;	GO:0045471~response to ethanol	9	100	9	0.0017431137242645	0.0521118373816574	1	1	0.866855798329807	0.999985158733297	0.44500680386917
down	CIDEA; TNFRSF21; S100A8; CEACAM5; CGB7; GJA1; MAL; KRT20; LGALS7; FAM3B; ECSCR; PHLDA2; MAGI3; UNC5B; PPP1R13L; PHLDA1; CSRNP3; TFAP2B; CIDEC; NOX5; PEG3; TP53AIP1; PTPRH; PAK6; PAK5; IL19; CASP14;	GO:0006915~apoptotic process	27	552	4.89130434782609	0.0017955981929999	0.0529792849535247	1	1	0.871667991567447	0.999985158733297	0.452414335264649
down	BMP2; ADRA2B; ADRA2C; HOXD3; IRX3; VWC2; SH3GL3; BRINP1;	GO:0045666~positive regulation of neuron differentiation	8	81	9.87654320987654	0.0018090487545106	0.0529792849535247	1	1	0.872917074888696	0.999985158733297	0.452414335264649
down	CACNA1G; GABRA3; GABRB2; GABRA4; HTR3B; GABRQ; CHRNB4; GABRR1; PIEZO2;	GO:0042391~regulation of membrane potential	9	102	8.82352941176471	0.00197661535187277	0.0571724516957021	1	1	0.887500292990873	0.999985158733297	0.488221703106252
down	HPGDS; GSTA1; PTGR1; CYP2S1;	GO:0006693~prostaglandin metabolic process	4	18	22.2222222222222	0.00201199220253168	0.0571724516957021	1	1	0.890078539327143	0.999985158733297	0.488221703106252
down	MT2A; MT1A; MT1H; MT1M;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.00201199220253168	0.0571724516957021	1	1	0.890078539327143	0.999985158733297	0.488221703106252
down	SCNN1B; SCNN1G; AMN; UGT1A7; ATP6V0A4;	GO:0007588~excretion	5	32	15.625	0.00220937000313337	0.0599891403121381	1	1	0.905655942575994	0.999985158733297	0.512274694934479
up	CXCR1; CXCR5; CCR2; CCR10; CXCR3; CCR5; CCR6; CCR8; GPR35; CCL26; CCL23; CCL21; PPBP; CCL24; CXCL3; XCL2; CXCL6; XCL1; PF4V1; PF4;	GO:0070098~chemokine-mediated signaling pathway	20	70	28.5714285714286	0.00222983507511199	0.493908469137305	1	1	0.99999999999994	0.99999999999994	1
down	CAV1; ECM1; IL36RN;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	3	8	37.5	0.00223652892452919	0.0599891403121381	1	1	0.907757107463589	0.999985158733297	0.512274694934479
down	WNT3; SFRP1; MDFI;	GO:0009950~dorsal/ventral axis specification	3	8	37.5	0.00223652892452919	0.0599891403121381	1	1	0.907757107463589	0.999985158733297	0.512274694934479
down	GJB1; GJA1; GJB2;	GO:0016264~gap junction assembly	3	8	37.5	0.00223652892452919	0.0599891403121381	1	1	0.907757107463589	0.999985158733297	0.512274694934479
down	DLG2; MAGI3; TJP2;	GO:0046710~GDP metabolic process	3	8	37.5	0.00223652892452919	0.0599891403121381	1	1	0.907757107463589	0.999985158733297	0.512274694934479
down	AQP1; SCNN1B; SCNN1G;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.00223652892452919	0.0599891403121381	1	1	0.907757107463589	0.999985158733297	0.512274694934479
down	TH; PSAPL1; ACER1; PDXDC2P;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00238756953776131	0.062865363058486	1	1	0.915482918054067	0.999985158733297	0.53683607591581
down	UNC13B; NTF4; GABRB2; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.00238756953776131	0.062865363058486	1	1	0.915482918054067	0.999985158733297	0.53683607591581
down	BMP2; BMP7; DLX5; SFRP1; TMEM100;	GO:0071773~cellular response to BMP stimulus	5	33	15.1515151515152	0.00249217658766188	0.0644373586179242	1	1	0.919613160847232	0.999985158733297	0.550260064682101
down	DKK1; AGR2; TFAP2A; AR; BMP2; BMP7; TNC; HOXD3; WNT5A; WNT3; POU3F1; CAV1; NR0B2; IL34; SEC16B; TRIM6; IL1F10; IL36A; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	20	374	5.3475935828877	0.00258889161016329	0.0663403475104343	1	1	0.923377338853914	0.999985158733297	0.56651055684288
down	HPGDS; TH; CHRNB4; NOVA1; SLURP1; NAV2; PAK6; PAK5;	GO:0007626~locomotory behavior	8	87	9.19540229885057	0.00273111998822362	0.0693656138601928	1	1	0.928721611948733	0.999985158733297	0.592344689293425
down	CYP1A1; CYP2C9; CYP3A5; UGT1A1;	GO:0008210~estrogen metabolic process	4	20	20	0.0028086706842908	0.0700946509905618	1	1	0.931984263313361	0.999985158733297	0.598570270650525
down	TF; EPCAM; DUOXA2; CCL19;	GO:2000147~positive regulation of cell motility	4	20	20	0.0028086706842908	0.0700946509905618	1	1	0.931984263313361	0.999985158733297	0.598570270650525
down	FOXN1; SOX15; TFAP2A; HOXA6; HNF4A; ID4; IRX4; IRX3; HOXC5; MESP2; ECM1; TFAP2C; DMRTA2; VGLL1; SOX7; DMRT3; STOX2; NHLH2; SP6; SPDEF; KLF8; HNF1B; HNF4G; ETV4; TFCP2L1; FOXI2; TFAP2B; KLF15; TBL1Y; DLX5; ZNF878; ZNF57; SIM2;	GO:0006357~regulation of transcription by RNA polymerase II	33	747	4.41767068273092	0.00288456370316703	0.0713680847249085	1	1	0.934663845669546	0.999985158733297	0.609444703495993
down	ELN; NPPC; PDE1A;	GO:0048660~regulation of smooth muscle cell proliferation	3	9	33.3333333333333	0.00292660461743244	0.0717893611284709	1	1	0.93651347757838	0.999985158733297	0.613042175304976
down	BMP2; AGXT; HOXD3; HNF1B; MESP2; NR0B2; HES5; TMEM100; SORBS2;	GO:0007219~Notch signaling pathway	9	109	8.25688073394496	0.00299678581548291	0.0722754226087054	1	1	0.93915023212876	0.999985158733297	0.617192876502074
down	GPR37; BCAR3; AR; BMP2; ADRA2B; ADRA2C; EFNA1; DAB2IP; ROR1;	GO:0043410~positive regulation of MAPK cascade	9	109	8.25688073394496	0.00299678581548291	0.0722754226087054	1	1	0.93915023212876	0.999985158733297	0.617192876502074
down	GLI3; EDN3; EDNRB; OCA2;	GO:0030318~melanocyte differentiation	4	21	19.047619047619	0.00327788083488412	0.0773554705027488	1	1	0.950303639103061	0.999985158733297	0.660573727963403
down	DEFB4A; S100A8; S100A7; CST9; ITLN1; PGLYRP3;	GO:0019730~antimicrobial humoral response	6	52	11.5384615384615	0.00328828132450709	0.0773554705027488	1	1	0.95031330278255	0.999985158733297	0.660573727963403
down	SCGB1A1; NQO1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	6	52	11.5384615384615	0.00328828132450709	0.0773554705027488	1	1	0.95031330278255	0.999985158733297	0.660573727963403
down	FOXN1; TREH; TH; BMP2; ELN; EFNB2; PHLDA2; LAMB4; EGFLAM;	GO:0009887~animal organ morphogenesis	9	111	8.10810810810811	0.00335373076109435	0.077979766130098	1	1	0.952901188999684	0.999985158733297	0.665904873740542
down	TFAP2A; HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	5	36	13.8888888888889	0.00349782335177373	0.077979766130098	1	1	0.958426485813687	0.999985158733297	0.665904873740542
down	WNT9A; AR; EDN3; PPP1R13L; SOX17;	GO:0045597~positive regulation of cell differentiation	5	36	13.8888888888889	0.00349782335177373	0.077979766130098	1	1	0.958426485813687	0.999985158733297	0.665904873740542
down	IL33; ADCYAP1; WNT5A; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.00358412424209087	0.077979766130098	1	1	0.9619722849865	0.999985158733297	0.665904873740542
down	DDR1; SHROOM2; STRA6;	GO:0043583~ear development	3	10	30	0.00373395488067052	0.077979766130098	1	1	0.96765198139906	0.999985158733297	0.665904873740542
down	DLG2; MAGI3; TJP2;	GO:0046037~GMP metabolic process	3	10	30	0.00373395488067052	0.077979766130098	1	1	0.96765198139906	0.999985158733297	0.665904873740542
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00373395488067052	0.077979766130098	1	1	0.96765198139906	0.999985158733297	0.665904873740542
down	UPK1B; TF; BMP2; NOS2; CAV1; FER1L6; MT1M; STOX2;	GO:0009617~response to bacterium	8	92	8.69565217391304	0.0037495497302974	0.077979766130098	1	1	0.96831174411365	0.999985158733297	0.665904873740542
down	GSTA4; HPGDS; GSTA1; GSTM3;	GO:1901687~glutathione derivative biosynthetic process	4	22	18.1818181818182	0.00379772548046708	0.078413468553529	1	1	0.970327516831499	0.999985158733297	0.669608457014105
down	EPCAM; BMP7; SDC1; SFRP1; ROBO2;	GO:0001657~ureteric bud development	5	37	13.5135135135135	0.00388965908761851	0.0791724934855683	1	1	0.973813916186271	0.999985158733297	0.676090117919477
down	AGR2; PTN; FOXF1; VWC2; EGFLAM;	GO:0010811~positive regulation of cell-substrate adhesion	5	37	13.5135135135135	0.00388965908761851	0.0791724934855683	1	1	0.973813916186271	0.999985158733297	0.676090117919477
down	PROM1; TFAP2A; FJX1; TFAP2B;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.00437066364981864	0.0881670227747923	1	1	0.992227269815544	0.999985158733297	0.752898515635158
down	KRT16; MIF; PTN; STC1; SLURP1; DPYSL3; SFRP1; MAPK15; LIMCH1;	GO:0030336~negative regulation of cell migration	9	116	7.75862068965517	0.00439299103024227	0.0881670227747923	1	1	0.992763300991587	0.999985158733297	0.752898515635158
up	TNF; APOA2; IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	5	6	83.3333333333333	0.00471780608101557	0.961811562332241	1	1	0.99999999999994	0.99999999999994	1
down	DKK1; BMP7; DLX5; FRAS1; HOXC10;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.0047658014400962	0.0943300009177661	1	1	0.993122324479438	0.999985158733297	0.805527003585683
down	TFAP2A; BMP2; BMP7; PTN; ADGRV1;	GO:0030501~positive regulation of bone mineralization	5	39	12.8205128205128	0.0047658014400962	0.0943300009177661	1	1	0.993122324479438	0.999985158733297	0.805527003585683
up	CD74; CD19; FCGR2B; PRKCD; TCIRG1; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	7	13	53.8461538461538	0.00477649082873799	0.961811562332241	1	1	0.99999999999994	0.99999999999994	1
down	GLI3; BMP2; BMP7; TNC; AMTN; SOSTDC1;	GO:0042475~odontogenesis of dentin-containing tooth	6	57	10.5263157894737	0.00496799644421075	0.0976011222184357	1	1	0.99333722916844	0.999985158733297	0.833460603861917
down	NPPC; EDNRB; AQP1; GUCY1B2;	GO:0019934~cGMP-mediated signaling	4	24	16.6666666666667	0.00499908186972475	0.0976011222184357	1	1	0.993362313441904	0.999985158733297	0.833460603861917
down	WNT9A; SPDEF; FGF1; HOXD4; EDN3; HOXB1; FLG; MEOX2; ODF4; SPATA19; DZIP1; CCL17; AMN; NPAP1; THEG; DKK4; NKX1-2; EPHA2; ROR1; DDR1; CDH19; CDH8; SPINK6; CDH17;	GO:0007275~multicellular organism development	24	513	4.67836257309941	0.00524396775091684	0.0992319537103075	1	1	0.993600016795204	0.999985158733297	0.847387019553845
down	BMP2; BMP7; WNT5A; FOXF2; AKNAD1;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.00525259478228113	0.0992319537103075	1	1	0.993600016795204	0.999985158733297	0.847387019553845
down	BMP7; HOXD3; WNT5A; LUM; HES5; IL17F;	GO:0051216~cartilage development	6	58	10.3448275862069	0.00536781488855809	0.0992319537103075	1	1	0.993713086498396	0.999985158733297	0.847387019553845
down	SCGB1A1; CMA1; WNT5A; DUOXA2; ACE2; BCL6B; IL1RL2;	GO:0050727~regulation of inflammatory response	7	78	8.97435897435897	0.00557835508334048	0.0992319537103075	1	1	0.993923186522725	0.999985158733297	0.847387019553845
down	GJA1; PTN; GJB2; STC1;	GO:0046697~decidualization	4	25	16	0.00568528880179442	0.0992319537103075	1	1	0.994050833499739	0.999985158733297	0.847387019553845
down	WNT5A; WNT3; SEMA3F; SEMA6D;	GO:0048843~negative regulation of axon extension involved in axon guidance	4	25	16	0.00568528880179442	0.0992319537103075	1	1	0.994050833499739	0.999985158733297	0.847387019553845
down	KRT16; FLG; FLG2; HRNR;	GO:0061436~establishment of skin barrier	4	25	16	0.00568528880179442	0.0992319537103075	1	1	0.994050833499739	0.999985158733297	0.847387019553845
down	MT2A; MT1A; MT1H; MT1M;	GO:0071294~cellular response to zinc ion	4	25	16	0.00568528880179442	0.0992319537103075	1	1	0.994050833499739	0.999985158733297	0.847387019553845
down	DKK1; SOX7; SOX17;	GO:0001706~endoderm formation	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	GPIHBP1; MFSD2A; RAB17;	GO:0045056~transcytosis	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	BMP2; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	PTN; TNC; SFRP1;	GO:0071305~cellular response to vitamin D	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	PLXNB1; WNT5A; GABRB2;	GO:1904862~inhibitory synapse assembly	3	12	25	0.00572229860748497	0.0992319537103075	1	1	0.99408366754874	0.999985158733297	0.847387019553845
down	GJA1; WNT5A; ID4; DUOXA2; AJUBA; FRMD6;	GO:0034613~cellular protein localization	6	59	10.1694915254237	0.00579066551364005	0.0992319537103075	1	1	0.994150487718637	0.999985158733297	0.847387019553845
down	EPHA2; APLNR; CAV1; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	6	60	10	0.00623729263622042	0.101135761954534	1	1	0.994586709959847	0.999985158733297	0.863644508533525
down	MUC3A; MUC21; B3GNT6; GALNT12; MUC15; MUC13;	GO:0016266~O-glycan processing	6	60	10	0.00623729263622042	0.101135761954534	1	1	0.994586709959847	0.999985158733297	0.863644508533525
down	BCHE; SCGB1A1; IGFBP2; SDC1; AGXT; WNT7B;	GO:0051384~response to glucocorticoid	6	60	10	0.00623729263622042	0.101135761954534	1	1	0.994586709959847	0.999985158733297	0.863644508533525
down	BRINP1; INHA; BMP2; BMP7; ADCYAP1;	GO:0045786~negative regulation of cell cycle	5	42	11.9047619047619	0.00632975389723001	0.102058391489046	1	1	0.994665896799812	0.999985158733297	0.871523263936086
down	GJB3; TRIP10; FRAS1; CCL19;	GO:0007154~cell communication	4	26	15.3846153846154	0.00643151051473745	0.102546862096092	1	1	0.994788533561706	0.999985158733297	0.875694537768431
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	4	26	15.3846153846154	0.00643151051473745	0.102546862096092	1	1	0.994788533561706	0.999985158733297	0.875694537768431
up	HBZ; HBD; HBQ1; HBG1; HBG2; HBA1; HBM;	GO:0015671~oxygen transport	7	14	50	0.00647479061905409	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	PLA2G10; LIPI; ASPG; PLA2G3; PNLIPRP3; CES3; LIPG;	GO:0016042~lipid catabolic process	7	81	8.64197530864197	0.00672869745692539	0.105678991923167	1	1	0.995094152158806	0.999985158733297	0.902441226307584
down	NQO1; NOS1; NOS2;	GO:0006809~nitric oxide biosynthetic process	3	13	23.0769230769231	0.0069126037855316	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	GABRB2; GABRA4; GABRA3;	GO:0051932~synaptic transmission, GABAergic	3	13	23.0769230769231	0.0069126037855316	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	MMP12; WNT5A; TRIM6;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	3	13	23.0769230769231	0.0069126037855316	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	EPHA2; CCL11; DDR1;	GO:0060444~branching involved in mammary gland duct morphogenesis	3	13	23.0769230769231	0.0069126037855316	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	CYP1A1; HNF1B; HNF4A;	GO:0070365~hepatocyte differentiation	3	13	23.0769230769231	0.0069126037855316	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	MMP7; MMP10; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	5	43	11.6279069767442	0.00692252630019352	0.105678991923167	1	1	0.995282225141637	0.999985158733297	0.902441226307584
down	SLC34A2; GLI3; IGFBP2; GSTM3; CCND1; CAV1;	GO:0043627~response to estrogen	6	62	9.67741935483871	0.00720484041490055	0.108221217857259	1	1	0.99553264840682	0.999985158733297	0.924150455812541
down	GABRR1; GABRB2; GABRA4; GABRA3;	GO:0007214~gamma-aminobutyric acid signaling pathway	4	27	14.8148148148148	0.00723988635142636	0.108221217857259	1	1	0.995584926548311	0.999985158733297	0.924150455812541
down	GLI3; HOXC10; HOXD9; HOXC9;	GO:0009954~proximal/distal pattern formation	4	27	14.8148148148148	0.00723988635142636	0.108221217857259	1	1	0.995584926548311	0.999985158733297	0.924150455812541
down	PLA2G10; PLA2G4E; PLA2G4F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	4	27	14.8148148148148	0.00723988635142636	0.108221217857259	1	1	0.995584926548311	0.999985158733297	0.924150455812541
down	EDN3; EDNRB; NRTN; SEMA3F; SEMA6D;	GO:0001755~neural crest cell migration	5	44	11.3636363636364	0.00755300210823373	0.111675861098118	1	1	0.995915356328114	0.999985158733297	0.953651233838536
down	FGF1; KRT18; TH; HOXC13; EFNB2; SOX17; SOX15; SOX7; FOXI2;	GO:0009653~anatomical structure morphogenesis	9	127	7.08661417322835	0.00755354292184707	0.111675861098118	1	1	0.995915356328114	0.999985158733297	0.953651233838536
down	PLA2G10; HNF4A; CAV1; MALL; GPIHBP1; LIPG; CYP39A1;	GO:0042632~cholesterol homeostasis	7	83	8.43373493975904	0.00758773272269442	0.111675861098118	1	1	0.995915356328114	0.999985158733297	0.953651233838536
up	IRGM; LTF; RNASE2; RNASE3; DEFA4; SELP; AZU1; GSDMD; PRB3; FCN2; LYPD8; RNASE6; OPTN; TLR9; PYCARD; LYZL6; BPI; CAMP; TNFRSF14; DEFA3;	GO:0050829~defense response to Gram-negative bacterium	20	80	25	0.00780668395241313	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	COBL; CYP1A1; CLDN18; FOXF1;	GO:0048565~digestive tract development	4	28	14.2857142857143	0.00811246535333987	0.11723725639582	1	1	0.996471940916226	0.999985158733297	1
down	EDN2; EDNRB; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00823887873532869	0.11723725639582	1	1	0.996606964214453	0.999985158733297	1
down	AGR2; SFRP1; STRA6;	GO:0048546~digestive tract morphogenesis	3	14	21.4285714285714	0.00823887873532869	0.11723725639582	1	1	0.996606964214453	0.999985158733297	1
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.00823887873532869	0.11723725639582	1	1	0.996606964214453	0.999985158733297	1
down	SCNN1B; SCNN1G; TFAP2B;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.00823887873532869	0.11723725639582	1	1	0.996606964214453	0.999985158733297	1
up	TNF; APOA2; CD74; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	7	15	46.6666666666667	0.00858394188542955	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	FGF1; CMA1; AQP1; APLNR; WNT5A; CCL11; ECM1; CCBE1; ANGPTL4;	GO:0045766~positive regulation of angiogenesis	9	131	6.87022900763359	0.00905430498314119	0.1197504852609	1	1	0.997355729777349	0.999985158733297	1
down	TFAP2A; GLI3; MEOX2; DLX5; FOXF2; FRAS1;	GO:0060021~roof of mouth development	6	66	9.09090909090909	0.00945761917707255	0.124140498123306	1	1	0.99778359581329	0.999985158733297	1
down	DKK1; WNT5A; VWC2; SOSTDC1; SFRP1;	GO:0030514~negative regulation of BMP signaling pathway	5	47	10.6382978723404	0.00968209739957726	0.124894420767911	1	1	0.997966373537381	0.999985158733297	1
down	KRT16; KRT33B; PPP1R13L;	GO:0042633~hair cycle	3	15	20	0.00970434001088649	0.124894420767911	1	1	0.998060450307133	0.999985158733297	1
down	ADCYAP1; ADCYAP1R1; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	3	15	20	0.00970434001088649	0.124894420767911	1	1	0.998060450307133	0.999985158733297	1
down	TH; BMP7; FOXF2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.00970434001088649	0.124894420767911	1	1	0.998060450307133	0.999985158733297	1
down	MAL; GABRA4; POU6F2; NHLH2; UGT8; KLK6; SH3GL3; ROBO2; SPINK6;	GO:0007417~central nervous system development	9	133	6.76691729323308	0.00988430627927239	0.126079817873386	1	1	0.998254248452824	0.999985158733297	1
down	MT1A; MT1H; MT1M; MT2A;	GO:0006882~cellular zinc ion homeostasis	4	30	13.3333333333333	0.0100579596746422	0.126416933136795	1	1	0.99835408386121	0.999985158733297	1
down	GJA1; ADRA2C; HRH1; CAV1;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.0100579596746422	0.126416933136795	1	1	0.99835408386121	0.999985158733297	1
down	WNT3; SHROOM2; TFCP2L1; CDH17; CDH8; CDH19; CAP2;	GO:0000902~cell morphogenesis	7	88	7.95454545454545	0.010086926023807	0.126416933136795	1	1	0.99845595672691	0.999985158733297	1
down	MIF; NTF3; NOS1; WNT5A; CAV1; TRIM6; BCAR3;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	7	88	7.95454545454545	0.010086926023807	0.126416933136795	1	1	0.99845595672691	0.999985158733297	1
down	P4HA2; RDH16; AKR7A3; IDO1; GPX2; NDUFA4L2;	GO:0022900~electron transport chain	6	68	8.82352941176471	0.010754352897133	0.13419562093379	1	1	0.999113701098931	0.999985158733297	1
down	DKK1; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	4	31	12.9032258064516	0.0111344964866735	0.136405644773978	1	1	0.999475830022852	0.999985158733297	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.0111565578090485	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	KLK8; NFASC; MAPT; WNT7B; PCDHGC3;	GO:0050808~synapse organization	5	49	10.2040816326531	0.0113105792416963	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	EDN3; EDN2; ACE2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	CXCL10; BMP7; STC1;	GO:0033280~response to vitamin D	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	WNT5A; KLK6; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	AR; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	3	16	18.75	0.011311687615403	0.136405644773978	1	1	0.999602026466037	0.999985158733297	1
down	CXCL11; CXCL10; CCL11; CXCL9; CCL17; CCL19;	GO:0070098~chemokine-mediated signaling pathway	6	70	8.57142857142857	0.0121721083093005	0.136995885677225	1	1	0.999985158733297	0.999985158733297	1
down	DKK1; BMP7; WNT3; MESP2;	GO:0001707~mesoderm formation	4	32	12.5	0.0122824756489837	0.137162276702658	1	1	0.999985158733297	0.999985158733297	1
up	DRD5; AVPR1A; AVPR1B; AVPR2;	GO:0001992~regulation of systemic arterial blood pressure by vasopressin	4	5	80	0.0128326556033445	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	KRT16; CA9; FRAS1;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.0130631356059985	0.144753664823226	1	1	0.999985158733297	0.999985158733297	1
down	WNT5A; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	3	17	17.6470588235294	0.0130631356059985	0.144753664823226	1	1	0.999985158733297	0.999985158733297	1
down	SLC44A4; MFSD2A; SLC44A5; LPIN3;	GO:0006656~phosphatidylcholine biosynthetic process	4	33	12.1212121212121	0.0135034581514422	0.146798957934239	1	1	0.999985158733297	0.999985158733297	1
down	ADCYAP1; HNF1B; FAM3B; PCLO;	GO:0030073~insulin secretion	4	33	12.1212121212121	0.0135034581514422	0.146798957934239	1	1	0.999985158733297	0.999985158733297	1
down	WNT9A; TFAP2A; HOXD9; WNT3;	GO:0035115~embryonic forelimb morphogenesis	4	33	12.1212121212121	0.0135034581514422	0.146798957934239	1	1	0.999985158733297	0.999985158733297	1
down	SDC1; AQP1; AQP5; TUFT1;	GO:0042476~odontogenesis	4	33	12.1212121212121	0.0135034581514422	0.146798957934239	1	1	0.999985158733297	0.999985158733297	1
down	NOS1; WNT3; HES5; HES2;	GO:0050767~regulation of neurogenesis	4	33	12.1212121212121	0.0135034581514422	0.146798957934239	1	1	0.999985158733297	0.999985158733297	1
down	BMP7; HNF4A; ESRRG; HNF4G; NR0B2;	GO:0043401~steroid hormone mediated signaling pathway	5	52	9.61538461538462	0.0140877680591317	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	ZBTB7C; BMP2; MEDAG; SFRP1; RARRES2;	GO:0045600~positive regulation of fat cell differentiation	5	52	9.61538461538462	0.0140877680591317	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	ARHGEF15; S100A10; SFRP1; SYNPO2L; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	5	52	9.61538461538462	0.0140877680591317	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	CYP1A1; PAX1; DLX5; OCA2; CSPG4; FAM83A; RHBDF1; PAK5; LIPG;	GO:0008283~cell population proliferation	9	142	6.33802816901408	0.0143446530049086	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	DEFB4A; EPHA2; LCE3A; PGLYRP4; PGLYRP3; RARRES2; GBP6;	GO:0050830~defense response to Gram-positive bacterium	7	95	7.36842105263158	0.014525800801137	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	COL4A1; TNC; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	4	34	11.7647058823529	0.0147989030413669	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	GJB3; FRAS1; TFAP2B; ABCB6;	GO:0043588~skin development	4	34	11.7647058823529	0.0147989030413669	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	FOXP2; EDN2; FOXF1; STRA6;	GO:0048286~lung alveolus development	4	34	11.7647058823529	0.0147989030413669	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	RBFOX2; VLDLR; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	4	34	11.7647058823529	0.0147989030413669	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	PLA2G10; PLA2G4F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	3	18	16.6666666666667	0.014960441321701	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	GLI3; HNF1B; FOXF1;	GO:0048557~embryonic digestive tract morphogenesis	3	18	16.6666666666667	0.014960441321701	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	GLI3; AQP5; SHROOM2;	GO:0048593~camera-type eye morphogenesis	3	18	16.6666666666667	0.014960441321701	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	CXCL10; S100A7; CXCL17;	GO:0090026~positive regulation of monocyte chemotaxis	3	18	16.6666666666667	0.014960441321701	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	TNFRSF21; NFASC; MAL; KLK6; MALL;	GO:0042552~myelination	5	53	9.43396226415094	0.0151065875624238	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	FOXF1; DPYSL3; IL1F10; IL1RL2; CRNN;	GO:0071345~cellular response to cytokine stimulus	5	53	9.43396226415094	0.0151065875624238	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	NOS2; WNT5A; GBP6; RAB7B; CCL17; CCL19; CCL11;	GO:0071346~cellular response to interferon-gamma	7	96	7.29166666666667	0.0152577215952606	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
down	CAV1; DUOXA2; PHYHIP; WNK4; SLC9A2; PARD3;	GO:0008104~protein localization	6	74	8.10810810810811	0.0153920944130896	0.151386614280021	1	1	0.999985158733297	0.999985158733297	1
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; AKAP12; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	8	22	36.3636363636364	0.015748828418832	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.0161701668370755	0.152189817186659	1	1	0.999985158733297	0.999985158733297	1
down	EDN2; IRX3; MFSD2A; MRAP2;	GO:0097009~energy homeostasis	4	35	11.4285714285714	0.0161701668370755	0.152189817186659	1	1	0.999985158733297	0.999985158733297	1
down	FGF1; FUT1; WNT5A; BCAR1; CCBE1;	GO:0010595~positive regulation of endothelial cell migration	5	54	9.25925925925926	0.0161734823142616	0.152189817186659	1	1	0.999985158733297	0.999985158733297	1
down	SORBS2; TF; CCL11; BCAR1; PDLIM3; SHROOM2; MYO5C; MYO1A;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.0163970194188277	0.153789038339985	1	1	0.999985158733297	0.999985158733297	1
down	MT1M; NOS1; NOS2;	GO:0007263~nitric oxide mediated signal transduction	3	19	15.7894736842105	0.0170049332878639	0.157809382960564	1	1	0.999985158733297	0.999985158733297	1
down	CIDEA; CIDEC; HILPDA;	GO:0034389~lipid droplet organization	3	19	15.7894736842105	0.0170049332878639	0.157809382960564	1	1	0.999985158733297	0.999985158733297	1
down	PLA2G10; PLA2G4E; PLA2G4F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.0170049332878639	0.157809382960564	1	1	0.999985158733297	0.999985158733297	1
down	FGF1; GHR; BMP2; ADRA2B; NTF3; WNT5A; CSPG4; CXCL17;	GO:0000187~activation of MAPK activity	8	122	6.55737704918033	0.0171005986413713	0.157809382960564	1	1	0.999985158733297	0.999985158733297	1
down	CXCL11; DEFB4A; CXCL10; CCL11; CXCL9; ECSCR; CCL17; RARRES2;	GO:0006935~chemotaxis	8	122	6.55737704918033	0.0171005986413713	0.157809382960564	1	1	0.999985158733297	0.999985158733297	1
down	CLEC3B; BMP7; NPPC; STC1; ECM1; ATP6V0A4;	GO:0001503~ossification	6	76	7.89473684210526	0.0172045463762123	0.158259769550414	1	1	0.999985158733297	0.999985158733297	1
down	BMP2; WNT3; WNT7B; WNT9A; WNT5A;	GO:0045165~cell fate commitment	5	55	9.09090909090909	0.0172893194642812	0.15853145962456	1	1	0.999985158733297	0.999985158733297	1
down	CXCL10; EDN3; ELN; MEOX2;	GO:0008015~blood circulation	4	36	11.1111111111111	0.0176185032581575	0.160524140796546	1	1	0.999985158733297	0.999985158733297	1
down	WNT9A; TTC23; SFRP1; DCDC2;	GO:0045880~positive regulation of smoothened signaling pathway	4	36	11.1111111111111	0.0176185032581575	0.160524140796546	1	1	0.999985158733297	0.999985158733297	1
down	SCNN1B; SCNN1G; FXYD3; SLC4A11; SLC5A5; SLC38A3;	GO:0006814~sodium ion transport	6	77	7.79220779220779	0.0181635162235014	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	GSTA4; GSTA1; GSTM3; HPGDS;	GO:0006749~glutathione metabolic process	4	37	10.8108108108108	0.019145063248014	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	EPCAM; HNF4A; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	3	20	15	0.0191975378504037	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	FOXN1; COL4A1; EFNB2;	GO:0048514~blood vessel morphogenesis	3	20	15	0.0191975378504037	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	GJA1; ADCYAP1; NPPC;	GO:0097755~positive regulation of blood vessel diameter	3	20	15	0.0191975378504037	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	DDR1; PAK6; FLRT1;	GO:1990138~neuron projection extension	3	20	15	0.0191975378504037	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
down	CXCL11; MCF2L; DEFB4A; GPR37; PLXNB1; RGS11; ADGRL2; GNA14; CXCL10; EDN3; PDE6A; ADRA2B; ADCYAP1; ADRA2C; EDN2; EDNRB; HRH1; APLNR; ADCYAP1R1; BDKRB1; PDE1A; BCAR1; CXCL9; ARHGEF16; PREX2; TAS1R3; NET1; NGEF; OR2I1P; ADGRV1; QRFPR; OXGR1; CCL19; GPR62; FZD10; GNG4; CCL11; CGB7; GPR87; MRGPRX3; GPR78; CCL17;	GO:0007186~G protein-coupled receptor signaling pathway	42	1152	3.64583333333333	0.0192734602162017	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
up	FCGR2B; TMEM176B; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	4	6	66.6666666666667	0.0194970158238226	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	SDC1; CCND1; SLC6A1; TNNT2; CAV1;	GO:0051592~response to calcium ion	5	57	8.7719298245614	0.0196711121088409	0.164706079681071	1	1	0.999985158733297	0.999985158733297	1
up	IRGM; ACOD1; CD14; VIM; TFPI; CEBPB; TBXA2R; IL10; CCR5; CXCL6; HAMP; IRF8; IL24; CEBPE; CARD16; LILRB2; TNIP2; LILRB1; NLRP7; GHSR; LITAF; PYCARD; DEFA4; PF4; PF4V1; CD80; NR1H2; NR1I2; CXCL3; DEFA3; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	32	163	19.6319018404908	0.0197742370214876	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	DKK1; MAPT; WNT5A; EFNB2;	GO:1901216~positive regulation of neuron death	4	38	10.5263157894737	0.0207508952649662	0.169190538097878	1	1	0.999985158733297	0.999985158733297	1
down	NKX2-8; AR; HOXD9; HOXD3; HOXC9; ABLIM2; PPP1R13L;	GO:0006351~transcription, DNA-templated	7	103	6.79611650485437	0.0211287934208191	0.171783674554535	1	1	0.999985158733297	0.999985158733297	1
down	CACNA1G; SLC34A2; SCNN1B; SCNN1G; SHROOM2; SLC4A11;	GO:0035725~sodium ion transmembrane transport	6	80	7.5	0.0212582508838819	0.172347966205483	1	1	0.999985158733297	0.999985158733297	1
down	WNT5A; FZD10; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	3	21	14.2857142857143	0.0215388045883946	0.173155095710624	1	1	0.999985158733297	0.999985158733297	1
down	PLA2G10; PLA2G4E; PLA2G4F;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.0215388045883946	0.173155095710624	1	1	0.999985158733297	0.999985158733297	1
down	KLK8; WNT5A; CDH8;	GO:0050807~regulation of synapse organization	3	21	14.2857142857143	0.0215388045883946	0.173155095710624	1	1	0.999985158733297	0.999985158733297	1
up	CLSTN1; MAPK10; RAB8A;	GO:0098969~neurotransmitter receptor transport to postsynaptic membrane	3	3	100	0.0221483128521849	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0221483128521849	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	HLA-B; CEBPB; LILRB2;	GO:2001198~regulation of dendritic cell differentiation	3	3	100	0.0221483128521849	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	GLI3; BMP7; ID4; IRX3; HES5;	GO:0045665~negative regulation of neuron differentiation	5	59	8.47457627118644	0.0222581820113035	0.177941455076437	1	1	0.999985158733297	0.999985158733297	1
down	TF; BMP2; BMP7; HNF4A; INHA;	GO:0060395~SMAD protein signal transduction	5	59	8.47457627118644	0.0222581820113035	0.177941455076437	1	1	0.999985158733297	0.999985158733297	1
down	MT1A; MT1H; MT1M; MT2A;	GO:0071276~cellular response to cadmium ion	4	39	10.2564102564103	0.0224369458230071	0.178872318088974	1	1	0.999985158733297	0.999985158733297	1
up	PF4; IL10; CXCR5; CNR2; PPBP; PF4V1; CXCL6; CXCL3;	GO:0030595~leukocyte chemotaxis	8	24	33.3333333333333	0.0231011606966046	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	ARHGAP6; VIL1; AIF1; CORO7; LMOD2; CATIP; MICALL2; MSRB1; MSRB2;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.0231603400800481	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	CHP2; WNT5A; ACER1; ADGRV1; SYT7; SYT8;	GO:0071277~cellular response to calcium ion	6	82	7.31707317073171	0.0235083100852282	0.186378038521008	1	1	0.999985158733297	0.999985158733297	1
down	GLI3; BMP2; BMP7; NPPC; WNT7B;	GO:0045669~positive regulation of osteoblast differentiation	5	60	8.33333333333333	0.0236304750527729	0.186830477689968	1	1	0.999985158733297	0.999985158733297	1
down	TFF1; CYP1A1; TH;	GO:0035902~response to immobilization stress	3	22	13.6363636363636	0.0240289305548029	0.187041041108841	1	1	0.999985158733297	0.999985158733297	1
up	TARM1; SDCBP; FCN1; MAN2B1; SIGLEC5; TYROBP; GMFG; FCGR3B; PGLYRP1; TRPM2; HP; CFD; PLAU; HLA-B; HLA-H; ORM1; PPBP; LTF; FTL; CTSD; ELANE; CD14; RNASE2; GAA; CTSA; FCGR2A; RNASE3; DEFA4; CYBA; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; STOM; PTPN6; FCER1G; CEACAM8; CEACAM3; MNDA; CAMP; P2RX1; HK3; NCKAP1L; GSDMD; SNAP25; B2M; NPC2; ADAM8; S100A12; RHOG; TNFAIP6; PRKCD; SIGLEC14; TCIRG1; RAB31; COTL1; MVP; STXBP2; QPCT; CLEC12A; DOK3; TMEM179B; LILRB2; PLEKHO2; CLEC4C; RAB24; MS4A3; CNN2; ADGRE3; RHOF; RETN; CMTM6; CD300A; PYCARD; LAMTOR2; TRAPPC1;	GO:0043312~neutrophil degranulation	79	483	16.3561076604555	0.0249081753199921	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	CRYAB; WNT5A; SLITRK6; CRYBA2;	GO:0002088~lens development in camera-type eye	4	41	9.75609756097561	0.0260529837226664	0.196252134603813	1	1	0.999985158733297	0.999985158733297	1
down	FOXP2; WNT5A; FOXF1;	GO:0002053~positive regulation of mesenchymal cell proliferation	3	23	13.0434782608696	0.0266677833905565	0.199313901903378	1	1	0.999985158733297	0.999985158733297	1
down	ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0266677833905565	0.199313901903378	1	1	0.999985158733297	0.999985158733297	1
down	MMP12; CCL19; TRIM6;	GO:0098586~cellular response to virus	3	23	13.0434782608696	0.0266677833905565	0.199313901903378	1	1	0.999985158733297	0.999985158733297	1
up	DBH; HRH2; F2R; HTR2A; CASR; AVPR1B; AVPR2; AVPR1A; TBXA2R;	GO:0045907~positive regulation of vasoconstriction	9	30	30	0.0271780069626546	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	FCGR2B; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.0279422785339823	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	CA12; AQP1; CA9; SLC4A11;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.0279843623243055	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	DKK1; LYPD6; GPIHBP1; DKK4;	GO:2000272~negative regulation of signaling receptor activity	4	42	9.52380952380952	0.0279843623243055	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	SLITRK6; PCDHB10; PCDHB5; PCDHB11; PCLO;	GO:0007416~synapse assembly	5	63	7.93650793650794	0.0280700026927982	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	BMP2; EFNA1; CCND1; EDNRB; HSPA2; IL34; ITLN1; RARRES2; LIMCH1;	GO:0001934~positive regulation of protein phosphorylation	9	161	5.59006211180124	0.028371677551676	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	EFNA1; DAB2IP; SFRP1;	GO:0010719~negative regulation of epithelial to mesenchymal transition	3	24	12.5	0.0294549233581021	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CXCL10; CXCL11; CXCL9;	GO:0030595~leukocyte chemotaxis	3	24	12.5	0.0294549233581021	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CXCL10; SOSTDC1; CCL17;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.0294549233581021	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	PLA2G10; PLA2G4F; PLA2G3;	GO:0050482~arachidonic acid secretion	3	24	12.5	0.0294549233581021	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	ADCYAP1; PTN; WNT5A; DPYSL3; DAB2IP; NDRG4; ROR1;	GO:0010976~positive regulation of neuron projection development	7	111	6.30630630630631	0.0295710885146714	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CLCA1; BMP7; PTN; AQP1; STC1; SFRP1; HILPDA;	GO:0071456~cellular response to hypoxia	7	111	6.30630630630631	0.0295710885146714	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	RGS11; ADCYAP1; GNG4; KCTD8;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	4	43	9.30232558139535	0.0299987445035443	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	EFNB2; CDH8; CDH17; CDH19;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.0299987445035443	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	INHA; BMP2; PAX1; BMP7; EPHA2; DLX5; HOXC10; HOXD4;	GO:0001501~skeletal system development	8	137	5.83941605839416	0.0304027539017387	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	GLI3; FOXF1; HES5; DZIP1; BOC;	GO:0007224~smoothened signaling pathway	5	65	7.69230769230769	0.0313041226231643	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	S1PR4; HTR2A; AVPR1A; AVPR1B; NTRK2; P2RY12; NMUR1; GPR55; ARHGAP6;	GO:0007202~activation of phospholipase C activity	9	31	29.0322580645161	0.0316617626654112	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	CLEC3B; BMP2; PTN; TUFT1;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.0320965825222486	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	EDNRB; ADGRV1; GPR87;	GO:0007194~negative regulation of adenylate cyclase activity	3	25	12	0.0323896243367314	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CXCL10; PTN; EPHA2; ECSCR; DAB2IP; IL17F;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.0326215744461082	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	TYROBP; IFNG; THBS1; AZU1; TNFRSF8; CCR2; AKAP12;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	7	21	33.3333333333333	0.0326804350009697	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	TNFSF11; TNFRSF13B; ST18; TNFSF13; TNF; TNFRSF1A; PSMB8; PSMB9; TNFRSF8; CD40LG; CD70; PSMB10; TNFRSF4; PSMB3; TNFRSF17; PSME1; TRADD; COMMD7; PSMA8; PSMF1; TNFRSF14; TNFRSF12A; PYCARD; TNFRSF18;	GO:0033209~tumor necrosis factor-mediated signaling pathway	24	120	20	0.0334070936375457	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	ABO; FUT1; FUT6; ST6GAL2; B3GNT6; B3GALT5;	GO:0006486~protein glycosylation	6	90	6.66666666666667	0.0340862794058377	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CYP1A1; BMP2; FOXF1; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	4	45	8.88888888888889	0.0342782341145409	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	GJA1; HNF1B; HNF4A; GYS2; NR0B2;	GO:0009749~response to glucose	5	67	7.46268656716418	0.0347622377283356	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.0355210111179403	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	OXT; CRHBP; AVPR1A;	GO:0002125~maternal aggressive behavior	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	TNFSF11; CSF1; TCIRG1;	GO:0002158~osteoclast proliferation	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	HLA-DRA; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	F10; F7; TFPI;	GO:0007598~blood coagulation, extrinsic pathway	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.0355381572465956	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	OTOP3; OTOP2; SLC4A11; NOX5; ATP6V0A4; NDUFA4L2; SLC9A2;	GO:1902600~proton transmembrane transport	7	116	6.03448275862069	0.0358637877968238	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	PAX1; WNT5A; FOXF1; MESP2;	GO:0001756~somitogenesis	4	46	8.69565217391304	0.0365439642663491	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	EDNRB; HNF1B; LUM; SFRP1;	GO:0014070~response to organic cyclic compound	4	46	8.69565217391304	0.0365439642663491	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	DKK1; GJA1; IGFBP2; GJB2;	GO:0032526~response to retinoic acid	4	46	8.69565217391304	0.0365439642663491	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	BMP2; GJB2; ROR1; ADGRV1;	GO:0048839~inner ear development	4	46	8.69565217391304	0.0365439642663491	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	DEFB4A; CXCL10; MIF; NTF3;	GO:0050918~positive chemotaxis	4	46	8.69565217391304	0.0365439642663491	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	SYT7; ADRA2C; NOS2; HNF4A; TFAP2B;	GO:0050796~regulation of insulin secretion	5	68	7.35294117647059	0.0365762844487426	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	ADCY5; ADORA3; P2RY12; GNAI2;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	4	8	50	0.0382430035429479	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	BCL3; IL10; LILRB1; GHSR;	GO:0042536~negative regulation of tumor necrosis factor biosynthetic process	4	8	50	0.0382430035429479	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	TNF; IFNG; LRPAP1; MYOCD;	GO:1900222~negative regulation of amyloid-beta clearance	4	8	50	0.0382430035429479	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	ELANE; SELP; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	4	8	50	0.0382430035429479	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
up	CCL21; TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.0384965085890081	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	ADCYAP1; ADCYAP1R1; PCLO;	GO:0019933~cAMP-mediated signaling	3	27	11.1111111111111	0.0386974919667369	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	GHR; NPPC; MFSD2A;	GO:0040014~regulation of multicellular organism growth	3	27	11.1111111111111	0.0386974919667369	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CDH19; CDH17; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	3	27	11.1111111111111	0.0386974919667369	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	BDKRB1; NOS2; NOS1;	GO:0045776~negative regulation of blood pressure	3	27	11.1111111111111	0.0386974919667369	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	HNF4A; GPIHBP1; ANGPTL4;	GO:0070328~triglyceride homeostasis	3	27	11.1111111111111	0.0386974919667369	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	TFF1; TH; GJA1; BMP7;	GO:0043434~response to peptide hormone	4	47	8.51063829787234	0.0388939471091598	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CIDEA; NOVA1; HOXC10; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	4	47	8.51063829787234	0.0388939471091598	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	HOXD9; NTF4; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	4	48	8.33333333333333	0.041328267918288	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	NTF3; NRTN; BCAR1; NTF4; DDR1; EPHA2; ROR1;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	7	120	5.83333333333333	0.041490991230598	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	ELN; EFNA1; ROBO2;	GO:0003180~aortic valve morphogenesis	3	28	10.7142857142857	0.0420679497112678	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	TGM3; SOSTDC1; KRT27;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.0420679497112678	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	TNFRSF10B; TNF; TNFRSF1A; FASLG; BID; BAX; TRADD; DEDD2; DAXX;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	9	33	27.2727272727273	0.0421132024414698	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	NQO1; CYP2F1; SLC6A1; SLC7A8; PON3;	GO:0009636~response to toxic substance	5	71	7.04225352112676	0.04236217596321	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CHRNB4; CLDN10; SLC5A5; WNK4; SLC25A10; SLC9A2;	GO:0006811~ion transport	6	96	6.25	0.0437625982997397	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CBR3; MFSD2A; STRA6; TMPRSS11E;	GO:0050890~cognition	4	49	8.16326530612245	0.0438469252035796	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	GPX1; HBA1; HBG2; HBZ; HBD; HBQ1; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	8	28	28.5714285714286	0.0444015608637189	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	FOXN1; CRISP3; CXCL9; TPSAB1; NOX5;	GO:0006952~defense response	5	72	6.94444444444444	0.0444062115711391	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	KRT20; CADPS2; SFRP1; MFSD2A; MYH13;	GO:0009267~cellular response to starvation	5	72	6.94444444444444	0.0444062115711391	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	C1QC; S100A8; KRT16; MIF; C4BPB; S100A7; CRISP3; DAB2IP; SUSD4; IL34; TRIL; PGLYRP4; PGLYRP3; RARRES2; TRIM31; IL1RL2; IL36B; IL36G; IL36RN; IL36A;	GO:0045087~innate immune response	20	505	3.96039603960396	0.0446670328157506	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	OGG1; APOA2; EIF2AK1; HP; HPR;	GO:0002526~acute inflammatory response	5	13	38.4615384615385	0.0447382874610448	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	IL33; SCGB1A1; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.0455805860241851	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	ADRA2C; EDNRB; TMEM100;	GO:0051930~regulation of sensory perception of pain	3	29	10.3448275862069	0.0455805860241851	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	PIGR; BCAR1; EFEMP1; FAM83A;	GO:0007173~epidermal growth factor receptor signaling pathway	4	50	8	0.0464498328805414	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	DLG2; ARFGEF3; CSRNP3; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	4	50	8	0.0464498328805414	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	MAPT; PTN; HRH1; FGF14;	GO:0048167~regulation of synaptic plasticity	4	50	8	0.0464498328805414	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
up	SPI1; RELB; IRF4; BATF; DCSTAMP; BATF3;	GO:0043011~myeloid dendritic cell differentiation	6	18	33.3333333333333	0.0465806336824558	0.962685143000972	1	1	0.99999999999994	0.99999999999994	1
down	CRYAB; GJA1; HNF4A; BDKRB1; GNG4; SFRP1; SOX17;	GO:0030308~negative regulation of cell growth	7	124	5.64516129032258	0.047661604688791	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	GJA1; C4BPB; WNT5A; DAB2IP; SOX17;	GO:0045732~positive regulation of protein catabolic process	5	74	6.75675675675676	0.0486684535874353	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	TMPRSS11D; ELN; SFTPA2;	GO:0007585~respiratory gaseous exchange by respiratory system	3	30	10	0.0492335243059963	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	CAPN8; GKN1; CYP39A1;	GO:0007586~digestion	3	30	10	0.0492335243059963	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	BMP7; WNT5A; TRIM6;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	3	30	10	0.0492335243059963	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	PIGR; PTN; DLG2;	GO:0043113~receptor clustering	3	30	10	0.0492335243059963	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
down	BCAR1; CSPG4; PLAT;	GO:0048008~platelet-derived growth factor receptor signaling pathway	3	30	10	0.0492335243059963	0.207301978278233	1	1	0.999985158733297	0.999985158733297	1
